Bone Health
Natural health product licensed in Canada
- Licence holder
- FoodState Incorporated
- NPN or DIN-HM
- 80069942
- Status
- Active licence
- Licence date
- 3 June 2016
- Revision date
- 8 December 2016
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 300 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Cholécalciférol Potency : 250 UI | 6.25 mcg | 25 µg |
| Vitamine D Source : Cholécalciférol | Not specified | Not calculated |
| Magnésium Source : Chlorure de magnésium | 75 mg | 300,000 µg |
| Vitamine K1 Source : Vitamine K1 | 15 mcg | 60 µg |
| Bore Source : Boron hydrolyzed vegetable protein (HVP) chelate | 750 mcg | Not calculated |
Non-medicinal ingredients
Cellulose, Acide stéarique, Gomme de Guar, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 2 days |
Uses authorised in Canada
Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in the absorption and use of calcium and phosphorus. Helps in connective tissue formation. Helps the body to metabolize fats and proteins. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps in tissue formation. Helps to maintain proper muscle function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood thinners, have been diagnosed with estrogen dependent cancer, or have a kidney disorder.
Source
Official Health Canada record, licence 80069942
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging